Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome

被引:16
作者
Gröne, D
Treudler, R
de Villiers, EM
Husak, R
Orfanos, CE
Zouboulis, CC [1 ]
机构
[1] Dessau Med Ctr, Dept Dermatol, D-06822 Dessau, Germany
[2] Dessau Med Ctr, Dept Immunol, D-06822 Dessau, Germany
[3] Univ Med Berlin, Charite, Dept Dermatol, Berlin, Germany
[4] Deutsch Krebsforschungszentrum, Dept Virol, Reference Ctr HPV Diag & Treatment, D-6900 Heidelberg, Germany
关键词
antiviral; cidofovir; human papilloma virus; myelodysplastic syndrome; warts;
D O I
10.1111/j.1468-3083.2006.01380.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment.
引用
收藏
页码:202 / 205
页数:4
相关论文
共 18 条
[1]   Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells [J].
Andrei, G ;
Snoeck, R ;
Schols, D ;
De Clercq, E .
ONCOLOGY RESEARCH, 2001, 12 (9-10) :397-408
[2]   Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon α-2b [J].
Armbruster, C ;
Kreuzer, A ;
Vorbach, H ;
Huber, M ;
Armbruster, C .
EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (04) :830-831
[3]   Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study [J].
Calista, D .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2000, 14 (06) :484-488
[4]   Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir [J].
Calista, D .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2000, 90 (06) :713-715
[5]   Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy [J].
Davis, MDP ;
Gostout, BS ;
McGovern, RM ;
Persing, DH ;
Schut, RL ;
Pittelkow, MR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (02) :340-343
[6]   RECURRENT ORAL CONDYLOMATA ACUMINATA AND HAIRY LEUKOPLAKIA - AN EARLY SIGN OF MYELODYSPLASTIC SYNDROME IN AN HIV-SERONEGATIVE PATIENT [J].
FICARRA, G ;
MILIANI, A ;
ADLERSTORTHZ, K ;
WOODSFRANCIS, K ;
DELMISTRO, A ;
DEROSSI, A ;
RICCARDI, R ;
RAVINA, A ;
DEMAIO, E .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1991, 20 (08) :398-402
[7]   Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV [J].
Hivnor, C ;
Shepard, JW ;
Shapiro, MS ;
Vittorio, CC .
ARCHIVES OF DERMATOLOGY, 2004, 140 (01) :13-14
[8]   Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients [J].
Husak, R ;
Zouboulis, CC ;
Sander-Bähr, C ;
Hummel, M ;
Orfanos, CE .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) :590-591
[9]   Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine [J].
Johnson, JA ;
Gangemi, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1198-1205
[10]   Human papillomavirus: clinical significance and malignant potential [J].
Nebesio, CL ;
Mirowski, GW ;
Chuang, TY .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (06) :373-379